首页> 外文期刊>International Journal of Clinical Oncology >Significance of irradiation in breast-conserving treatment: comparison of local recurrence rates in irradiated and nonirradiated groups
【24h】

Significance of irradiation in breast-conserving treatment: comparison of local recurrence rates in irradiated and nonirradiated groups

机译:放射线在保乳治疗中的意义:辐照组和未辐照组的局部复发率比较

获取原文
获取原文并翻译 | 示例
           

摘要

Breast-conserving treatment (BCT) is a standard therapy for early breast cancer. Many reports have described the effectiveness of post-BCT radiation therapy. However, the post-BCT local recurrence rate of only 5% to 10% indicates that radiation therapy may be unnecessary in many cases. To accurately select those patients who do not require post-BCT radiation therapy, we investigated the significance of irradiation in BCT by comparing local recurrence rates in irradiated and nonirradiated patients, grouped according to clinicopathological criteria that we evaluated. The patients were divided into two groups: a previous-criteria group and a present-criteria group. The former group included 85 patients in whom only two factors were considered as the criteria for radiation therapy: margin-positivity and lymphatic metastasis-positivity. The latter group included 318 patients in whom three additional factors were also considered: lymphatic invasion, intraductal extension, and metachronous/synchronous bilateral breast cancer. The use of five clinicopathological factors rather than two as the criteria for irradiation led to an increase in the irradiation ratio from 47.1% to 63.2% and a decrease in local recurrence from 12.9% to 2.2%. Because of the short average follow-up period of this study, further careful, regular follow-up and randomized comparative studies are required. It may also be necessary to include the patient age and margin condition as mandatory criteria for irradiation.
机译:保乳治疗(BCT)是早期乳腺癌的标准治疗方法。许多报告描述了BCT后放射治疗的有效性。但是,BCT后的局部复发率仅为5%至10%,表明在许多情况下可能不需要放射治疗。为了准确地选择那些不需要BCT放射治疗的患者,我们通过比较根据我们评估的临床病理标准分组的受照者和未受照者的局部复发率,调查了BCT中放疗的重要性。将患者分为两组:既往标准组和当前标准组。前一组包括85例患者,其中仅考虑两个因素作为放射治疗的标准:边缘阳性和淋巴转移阳性。后一组包括318例患者,其中还考虑了三个其他因素:淋巴管浸润,导管内扩张和异时/同步性双侧乳腺癌。使用五个临床病理因素而不是两个作为照射标准,导致照射率从47.1%增加到63.2%,局部复发率从12.9%减少到2.2%。由于本研究的平均随访期较短,因此需要进一步仔细,定期的随访和随机比较研究。也可能需要将患者的年龄和边缘状况纳入放射线的强制性标准。

著录项

  • 来源
    《International Journal of Clinical Oncology》 |2008年第1期|12-17|共6页
  • 作者单位

    Division of Surgical Oncology Tohoku University School of Medicine 1-1 Seiryo-machi Aoba-ku Sendai 980-8574 Japan;

    Division of Surgical Oncology Tohoku University School of Medicine 1-1 Seiryo-machi Aoba-ku Sendai 980-8574 Japan;

    Division of Surgical Oncology Tohoku University School of Medicine 1-1 Seiryo-machi Aoba-ku Sendai 980-8574 Japan;

    Division of Surgical Oncology Tohoku University School of Medicine 1-1 Seiryo-machi Aoba-ku Sendai 980-8574 Japan;

    Second Department of Pathology Kawasaki Medical School Kurashiki Japan;

    Division of Surgical Oncology Tohoku University School of Medicine 1-1 Seiryo-machi Aoba-ku Sendai 980-8574 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Breast cancer; Breast-conserving treatment (BCT); Radiation therapy;

    机译:乳腺癌;保乳治疗;放疗;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号